Sequenced Neurocognitive and Behavioral Parent Training for the Treatment of ADHD in School-age Children
Overview
Pediatrics
Psychology
Authors
Affiliations
The present study examines the potential of sequencing a neurocognitive intervention with behavioral parent training (BPT) to improve executive functions (EFs), psychiatric symptoms, and multiple indices of functional impairment in school-age children aged 7 to 11 years who have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Specifically, in a randomized controlled trial design, 85 children were assigned to either Cogmed Working Memory Training (CWMT) followed by an empirically supported, manualized BPT intervention, or to a placebo version of CWMT followed by the same BPT intervention. Working memory maintenance (i.e., attention control/short-term memory), working memory processing and manipulation, ADHD and oppositional defiant disorder (ODD) symptoms, impairment in parent-child dynamics, familial impairment, and overall functional compromise were evaluated as outcomes. The results suggest specific effects of the combined CWMT and BPT program on verbal and nonverbal working memory storage and nonverbal working memory processing and manipulation but no incremental benefits in regard to ADHD symptoms, ODD symptoms, and functional outcomes. The present findings do not support the hypothesis regarding the complementary and augmentative benefits of sequenced neurocognitive and BPT interventions for the treatment of ADHD. These results, the study's limitations, and future directions for research are further discussed.
Chacko A, Merrill B, Kofler M, Fabiano G Transl Psychiatry. 2024; 14(1):244.
PMID: 38851829 PMC: 11162428. DOI: 10.1038/s41398-024-02890-3.
Herrera-Morales W, Reyes-Lopez J, Tuz-Castellanos K, Ortegon-Abud D, Ramirez-Lugo L, Santiago-Rodriguez E J Pers Med. 2023; 13(9).
PMID: 37763129 PMC: 10533160. DOI: 10.3390/jpm13091361.
Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder.
Robinson C, Parker K, Kataria S, Downs E, Supra R, Kaye A Health Psychol Res. 2022; 10(3):38360.
PMID: 36168642 PMC: 9501833. DOI: 10.52965/001c.38360.
Yao A, Shimada K, Kasaba R, Tomoda A Front Psychiatry. 2022; 13:859249.
PMID: 35573335 PMC: 9094443. DOI: 10.3389/fpsyt.2022.859249.
Mattson J, Thorne J, Kover S Child Neuropsychol. 2022; 28(7):853-877.
PMID: 34978272 PMC: 10686097. DOI: 10.1080/09297049.2021.2023122.